SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 6.25 |
Enterprise Value ($M) | 2.15 |
Book Value ($M) | 3.75 |
Book Value / Share | 0.69 |
Price / Book | 1.66 |
NCAV ($M) | 3.51 |
NCAV / Share | 0.65 |
Price / NCAV | 1.78 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.56 |
Return on Assets (ROA) | -5.95 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.80 |
Current Ratio | 3.80 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 4.77 |
Assets | 5.01 |
Liabilities | 1.25 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -9.94 |
Net Income | -9.95 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -8.27 |
Cash from Investing | -0.15 |
Cash from Financing | 3.65 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Ault Milton C Iii | 40.30 | 62.95 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
25,958 | 67,843 | 38.26 | |
21,514 | 66,131 | 32.53 | |
35,326 | 133,462 | 26.47 | |
(click for more detail) |
Similar Companies | |
---|---|
ALGS – Aligos Therapeutics, Inc. | ALTS – JanOne Inc. |
ALVR – AlloVir, Inc. | ANEB – Anebulo Pharmaceuticals, Inc. |
ANIX – Anixa Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io